Balsa LM - Search Results

1

Exploring pta Alternatives in the Development of Ruthenium-Arene Anticancer Compounds.

Kljun J, Rebernik M, Balsa LM, Kladnik J, Rapuš U, Trobec T, Sepčić K, Frangež R, León IE, Turel I. Kljun J, et al. Among authors: balsa lm. Molecules. 2023 Mar 9;28(6):2499. doi: 10.3390/molecules28062499. Molecules. 2023. PMID: 36985471 Free PMC article.

2

Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres.

Balsa LM, Ruiz MC, Santa Maria de la Parra L, Baran EJ, León IE. Balsa LM, et al. J Inorg Biochem. 2020 Mar;204:110975. doi: 10.1016/j.jinorgbio.2019.110975. Epub 2019 Dec 26. J Inorg Biochem. 2020. PMID: 31911364

3

In silico and in vitro analysis of FAK/MMP signaling axis inhibition by VO-clioquinol in 2D and 3D human osteosarcoma cancer cells.

Balsa LM, Quispe P, Baran EJ, Lavecchia MJ, León IE. Balsa LM, et al. Metallomics. 2020 Dec 23;12(12):1931-1940. doi: 10.1039/d0mt00176g. Metallomics. 2020. PMID: 33107537

4

Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.

Balsa LM, Ferraresi-Curotto V, Lavecchia MJ, Echeverría GA, Piro OE, García-Tojal J, Pis-Diez R, González-Baró AC, León IE. Balsa LM, et al. Dalton Trans. 2021 Jul 21;50(28):9812-9826. doi: 10.1039/d1dt00869b. Dalton Trans. 2021. PMID: 34190268

5

Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres.

Balsa LM, Rodriguez MR, Parajón-Costa BS, González-Baró AC, Lavecchia MJ, León IE. Balsa LM, et al. ChemMedChem. 2022 Feb 16;17(4):e202100520. doi: 10.1002/cmdc.202100520. Epub 2021 Nov 17. ChemMedChem. 2022. PMID: 34750978

6

Copper Complexes as Antitumor Agents: In vitro and In vivo Evidence.

Balsa LM, Baran EJ, León IE. Balsa LM, et al. Curr Med Chem. 2023;30(5):510-557. doi: 10.2174/0929867328666211117094550. Curr Med Chem. 2023. PMID: 34789122 Review.

7

Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics.

Balsa LM, Rodriguez MR, Ferraresi-Curotto V, Parajón-Costa BS, Gonzalez-Baró AC, León IE. Balsa LM, et al. Int J Mol Sci. 2023 Apr 19;24(8):7531. doi: 10.3390/ijms24087531. Int J Mol Sci. 2023. PMID: 37108690 Free PMC article.

8

Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models.

Balsa LM, Solernó LM, Rodriguez MR, Parajón-Costa BS, Gonzalez-Baró AC, Alonso DF, Garona J, León IE. Balsa LM, et al. Chem Biol Interact. 2023 Oct 1;384:110685. doi: 10.1016/j.cbi.2023.110685. Epub 2023 Sep 4. Chem Biol Interact. 2023. PMID: 37666443

9

New copper(II) and oxidovanadium(IV) complexes with a vitamin B₆ Schiff base: mechanism of action and synergy studies on 2D and 3D human osteosarcoma cell models.

Balsa LM, Ferretti V, Sottile M, Nunes P, Costa Pessoa J, Correia I, León IE. Balsa LM, et al. Dalton Trans. 2024 Feb 13;53(7):3039-3051. doi: 10.1039/d3dt02964f. Dalton Trans. 2024. PMID: 38111362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page